Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy

被引：0
|
作者：
Smith-Uffen, Megan [1 ]
Park, John [2 ]
Parsonson, Andrew [2 ]
Vasista, Anuradha [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Nepean Blue Mountains Local Hlth Dist, Penrith, NSW, Australia
来源：
CANCER IMMUNOLOGY RESEARCH | 2022年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Circulating tumour DNA in patients with melanoma receiving targeted therapy
    Forschner, Andrea
    [J]. LANCET ONCOLOGY, 2021, 22 (03): : 291 - 293
  • [32] Targeted Therapy and Immunotherapy for Melanoma in Japan
    Namikawa, Kenjiro
    Yamazaki, Naoya
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (01)
  • [33] Combinations of Immunotherapy with targeted Therapy for Melanoma
    Gutzmer, Ralf
    Meier, Friedegund
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (08): : 928 - 929
  • [34] Combination of targeted therapy and immunotherapy in melanoma
    Blank, Christian U.
    Hooijkaas, Anna I.
    Haanen, John B.
    Schumacher, Ton N.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (10) : 1359 - 1371
  • [35] Targeted Therapy and Immunotherapy for Melanoma in Japan
    Kenjiro Namikawa
    Naoya Yamazaki
    [J]. Current Treatment Options in Oncology, 2019, 20
  • [36] Combination of targeted therapy and immunotherapy in melanoma
    Christian U. Blank
    Anna I. Hooijkaas
    John B. Haanen
    Ton N. Schumacher
    [J]. Cancer Immunology, Immunotherapy, 2011, 60 : 1359 - 1371
  • [37] Vitiligo-like depigmentation patterns in patients receiving immunotherapy for metastatic melanoma
    Zottarelli, Francesca
    Giorgione, Roberto
    Gironi, Laura C.
    Rinelli, Pamela Fa
    Sponghini, Andrea P.
    Rondonotti, David
    Savoia, Paola
    [J]. ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (01) : 97 - 99
  • [38] Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
    Yildiz, Ibrahim
    Bilici, Ahmet
    Karadurmus, Nuri
    Ozer, Leyla
    Tural, Deniz
    Kaplan, Mehmet A.
    Akman, Tulay
    Bayoglu, Ibrahim, V
    Uysal, Mukremin
    Yildiz, Yasar
    Tanriverdi, Ozgur
    Yazici, Ozan
    Surmeli, Zeki
    Turhal, Nazim Serdar
    Bavbek, Sevil
    Selcukbiricik, Fatih
    Koca, Dogan
    Basaran, Mert
    [J]. TUMORI JOURNAL, 2018, 104 (06): : 444 - 450
  • [39] ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH HER2 POSITIVE, METASTATIC BREAST CANCER (MBC) STARTING HER2 TARGETED THERAPIES
    Vasista, A.
    Stockler, M.
    West, T.
    Wilcken, N.
    Kiely, B.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 44 - 45
  • [40] Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly
    Ghate, Sameer R.
    Li, Zhiyi
    Tang, Jackson
    Nakasato, Antonio Reis
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (07): : 334 - 343
12345